Pulse Biosciences Inc (PLSE)
11.19
+0.18
(+1.63%)
USD |
NASDAQ |
Jun 28, 16:00
11.21
+0.02
(+0.18%)
Pre-Market: 20:00
Pulse Biosciences Cash from Investing (Quarterly): -0.005M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.005M |
| December 31, 2023 | -0.043M |
| September 30, 2023 | -0.023M |
| June 30, 2023 | -0.016M |
| March 31, 2023 | -0.039M |
| December 31, 2022 | -0.041M |
| September 30, 2022 | -0.062M |
| June 30, 2022 | -0.019M |
| March 31, 2022 | -0.279M |
| December 31, 2021 | -0.134M |
| September 30, 2021 | -0.157M |
| June 30, 2021 | -0.095M |
| March 31, 2021 | 7.949M |
| December 31, 2020 | 14.21M |
| September 30, 2020 | -22.57M |
| June 30, 2020 | 8.081M |
| March 31, 2020 | 10.32M |
| December 31, 2019 | 6.525M |
| Date | Value |
|---|---|
| September 30, 2019 | 6.554M |
| June 30, 2019 | 12.55M |
| March 31, 2019 | -35.73M |
| December 31, 2018 | 6.219M |
| September 30, 2018 | 5.989M |
| June 30, 2018 | 1.91M |
| March 31, 2018 | 12.00M |
| December 31, 2017 | -25.26M |
| September 30, 2017 | 3.842M |
| June 30, 2017 | 0.232M |
| March 31, 2017 | -1.81M |
| December 31, 2016 | -0.221M |
| September 30, 2016 | -13.60M |
| June 30, 2016 | -0.517M |
| March 31, 2016 | -0.039M |
| December 31, 2015 | -0.013M |
| September 30, 2015 | -0.039M |
| June 30, 2015 | -0.034M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-22.57M
Minimum
Sep 2020
14.21M
Maximum
Dec 2020
1.587M
Average
-0.023M
Median
Sep 2023
Cash from Investing (Quarterly) Benchmarks
| Align Technology Inc | -79.58M |
| NeuroOne Medical Technologies Corp | -0.0314M |
| SINTX Technologies Inc | -0.173M |
| Nutriband Inc | -0.0062M |
| enVVeno Medical Corp | 2.197M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -9.78M |
| Cash from Financing (Quarterly) | 0.305M |
| Free Cash Flow | -36.34M |
| Free Cash Flow Per Share (Quarterly) | -0.1774 |
| Free Cash Flow Yield | -6.19% |